Fiduciary Trust CO Biogen Inc. Transaction History

Fiduciary Trust CO

$6.98 Billion
Q3 2024

A detailed history of Fiduciary Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 3,234 shares of BIIB stock, worth $510,648. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,234

Previous 2,603 24.24%

Holding current value

$510,648

Previous $603,000 3.81%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $119,303 - $149,420	631 Added 24.24%	3,234 $626,000
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $15,622 - $19,411	-82 Reduced 3.05%	2,603 $603,000
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $5,300 - $6,692	-25 Reduced 0.92%	2,685 $578,000
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $23,149 - $27,865	-104 Reduced 3.7%	2,710 $701,000
Q2 2023 Aug 01, 2023	SELL	$275.25 - $318.06 $19,542 - $22,582	-71 Reduced 2.46%	2,814 $801,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4,867 - $6,711	-25 Reduced 0.86%	2,885 $771,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1,875 - $2,230	-10 Reduced 0.34%	2,910 $593,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $8,332 - $10,498	-43 Reduced 1.45%	2,920 $615,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $8,956 - $11,510	-40 Reduced 1.33%	2,963 $711,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $2,829 - $3,690	-10 Reduced 0.33%	3,003 $850,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $615,125 - $984,936	-2,375 Reduced 44.08%	3,013 $1.04 Million
Q1 2021 May 19, 2021	SELL	$242.95 - $284.63 $221,813 - $259,867	-913 Reduced 14.49%	5,388 $1.51 Million
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $127,580 - $192,040	-540 Reduced 7.89%	6,301 $1.54 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $248,883 - $287,367	940 Added 15.93%	6,841 $1.94 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $342,465 - $453,536	1,324 Added 28.93%	5,901 $1.58 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $26,347 - $33,421	98 Added 2.19%	4,577 $1.45 Million
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $140,838 - $194,604	640 Added 16.67%	4,479 $1.33 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $16,525 - $18,534	76 Added 2.02%	3,839 $894,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $76,970 - $84,843	-351 Reduced 8.53%	3,763 $880,000
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $1,083 - $1,694	-5 Reduced 0.12%	4,114 $972,000
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $11,697 - $14,815	-42 Reduced 1.01%	4,119 $1.24 Million
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $212,711 - $253,507	-826 Reduced 16.56%	4,161 $1.21 Million
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $321,260 - $454,368	-1,235 Reduced 19.85%	4,987 $1.37 Million
Q4 2017 Jan 29, 2018	SELL	$307.64 - $344.58 $12,920 - $14,472	-42 Reduced 0.67%	6,222 $1.98 Million
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $1.76 Million - $2.07 Million	6,264	6,264 $1.96 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Biogen Inc. Transaction History